Clinical Trials Sponsored by Thoratec Corporation

Total 6536 results

Abbott Medical Devices
Thoratec Corporation; Thoratec Europe Ltd

Completed

HeartMate 3 ELEVATE™ Registry (ELEVATE™)

Heart Failure | Cardiovascular Disease | Ventricular Dysfunction

Italy, United Kingdom, Denmark, Germany, Singapore, Czechia, Kazakhstan, Netherlands, Austria, Israel, Poland
Abbott Medical Devices
Thoratec Corporation

Completed

PREVENtion of HeartMate II Pump Thrombosis (PREVENT)

HeartMate II Pump Thrombosis

United States
Abbott Medical Devices
Thoratec Corporation

Completed

Driveline Silicone Skin Interface Registry (SSI)

Driveline Heart-assisted Device Related Infection

United States
University of Nebraska
Thoratec Corporation

Completed

Inhaled Milrinone Use in Patients Receiving HeartMate II LVAD: A Pilot Study

Right Ventricular Dysfunction | End Stage Heart Disease

United States
Abbott Medical Devices
Thoratec Corporation

Terminated

Thoratec Corporation HeartMate PHP™ Cardiogenic Shock Trial

Cardiogenic Shock

Hungary, Germany, Czechia, Netherlands
Abbott Medical Devices
Thoratec Corporation

Completed

CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass

Heart Failure

United States
Abbott Medical Devices
Thoratec Corporation

Completed

Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Destination Therapy

Cardiomyopathies | Ventricular Dysfunction | Heart Failure, Congestive

United States, Canada
Abbott Medical Devices
Thoratec Corporation

Completed

Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Bridge to Cardiac Transplantation

Cardiomyopathies | Ventricular Dysfunction | Heart Failure, Congestive

United States, Canada
Abbott Medical Devices
Thoratec Corporation

Completed

MOMENTUM 3 IDE Clinical Study Protocol (HM3™)

Advanced Refractory Left Ventricular Heart Failure

United States
University of Louisville
Thoratec Corporation

Unknown

Remission From Stage D Heart Failure (RESTAGE-HF)

Heart Failure NYHA Class III | Heart Failure NYHA Class IV

United States
Abbott Medical Devices
Thoratec Corporation

Completed

CentriMag RVAS U.S. Post-approval Study Protocol (CMagRVAS)

Right Ventricular Failure

United States
Abbott Medical Devices
Thoratec Corporation

Completed

Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device (LVAD) and Medical Management (ROADMAP)

Heart Failure

United States
Abbott Medical Devices
Thoratec Corporation

Completed

HeartMate 3™ LIS Study (HM 3 LIS)

Heart Failure | Cardiovascular Disease

Germany, Czechia
Abbott Medical Devices
Thoratec Corporation

Completed

Thoratec's Reduce Driveline Trauma Through Stabilization and Exit Site Management Study (RESIST)

Left Ventricular Assist Device | Percutaneous Lead Management

United States
Abbott Medical Devices
Thoratec Corporation

Withdrawn

CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass for Pediatric Patients

Heart Failure
University Hospital, Toulouse
Thoratec Corporation

Withdrawn

Bone Marrow-derived Mesenchymal Stem Cells (MSC) Administration in Weaning From Left Ventricular Assist Device (MESAD)

Chronic Myocardial Ischemia

France
Vanderbilt University Medical Center
Thoratec Corporation

Completed

Prospective Randomized Evaluation of an Ultra Conservative Approach to Implantable Defibrillator (ICD) Programming in Patients With a Left Ventricular Assist Device (LVAD).

Heart Failure

United States
Baylor College of Medicine
Thoratec Corporation

Completed

The IMPULSE Study: Pilot (IMPULSE)

Chronic Heart Failure

United States
Virginia Commonwealth University
Novartis; Thoratec Corporation

Completed

Safety Study of Octreotide Injection to Prevent GI Bleeding in Patients With Left Ventricular Assist Device (LVAD)

Gastrointestinal Bleeding

United States
Abbott Medical Devices
Thoratec Corporation; KCRI; Center for Life Sciences; Emergo

Completed

HeartMate 3™ CE Mark Clinical Investigation Plan (HM3 CE Mark)

Advanced Refractory Left Ventricular Heart Failure

Germany, Australia, Austria, Canada, Czechia, Kazakhstan
Abbott Medical Devices
Thoratec Europe Ltd

Completed

Screening for Advanced Heart Failure Treatment (SEE-HF) (SEE-HF)

Advanced Heart Failure | CRT and/or ICD

Netherlands, Sweden, Denmark, France, Germany, United Kingdom
Rennes University Hospital
Thoratec Europe Ltd

Withdrawn

LVAD in Non Cardiac Transplant Candidates and Non Responders to Resynchronization (CHECKMATE)

Heart Failure at NYHA Stage III or IV | Non Responders to Resynchronization | Non Candidates for Transplantation

France, Germany
Abbott Medical Devices
Thoratec Europe Ltd

Completed

Study of Reduced Anti-coagulation/Anti-platelet Therapy in Patients With the HeartMate II Left Ventricular Assist System (LVAS) (TRACE) (TRACE)

Anticoagulation | Left Ventricular Assist Device

United States, Austria, France, Germany, Czechia
Norton Thoracic Institute

Recruiting

Pain Relief After Hiatal Hernia Repair Surgery

Hiatal Hernia | Shoulder Pain

United States
Turkish Thoracic Society

Terminated

Turkish Thoracic Society Usual Interstitial Pneumonia Registry Study (TURK-UIP)

Idiopathic Pulmonary Fibrosis | Usual Interstitial Pneumonia

Turkey
British Thoracic Society

Completed

HRT Versus Etidronate for Osteoporosis and Fractures in Asthmatics Receiving Glucocorticoids.

Osteoporosis

United Kingdom
British Thoracic Society

Completed

Clarithromycin v Ciprofloxacin Added to Rifampicin + Ethambutol, for Opportunist Mycobacterial Pulmonary Disease

Pulmonary Diseases

United Kingdom
British Thoracic Society

Completed

3 Months' Versus 6 Months' Anticoagulation in Patients With DVT and/or PE

Deep Vein Thrombosis | Pulmonary Embolism | Deep Vein Thrombosis With Pulmonary Embolism

United Kingdom
Abbott Medical Devices
KU Leuven; Thoratec Corporation; Cliniques universitaires Saint-Luc- Université... and other collaborators

Completed

BeneMACS Study:HeartMate 2 (HM2)Left Ventricular Assist Device (LVAD) Survival in Non Transplant Patients is Equal/Better Than Results in Medical Literature (BeneMACs)

Heart Failure

Belgium
Thomas Jefferson University
Thoratec Corporation; National Skeletal Muscle Research Center; Greater New York...

Completed

Frailty: Prevalence and Response to Left Ventricular Assist Device Therapy in Older Heart Failure Patients

Systolic Heart Failure

United States
GenMont Biotech Incorporation
Biomedical Development Corporation

Completed

the Efficacy and Safety of Probiotics eN-Lac® Capsules of Children With Perennial Allergic Rhinitis (PAR)

Probiotics | Perennial Allergic Rhinitis | Lactobacillus Paracasei GMNL-32 (eN-Lac®)

Taiwan
Turkish Thoracic Society

Completed

Systemic Corticosteroids in Treatment of Post-COVID-19 Interstitial Lung Disease (STERCOV-ILD)

Covid19 | Interstitial Lung Disease | COVID-19 Pneumonia

Turkey
Thorsten Rudroff

Terminated

Transcranial Direct Current Stimulation to Lower Neuropathic Pain in People With Multiple Sclerosis

Multiple Sclerosis | Neuropathic Pain

United States
West Japan Thoracic Oncology Group

Completed

A Phase Ⅲ Randomized Study of Mitomycin/Vindesine/Cisplatin Versus Irinotecan/Carboplatin Versus Paclitaxel/Carboplatin With Concurrent Thoracic Radiotherapy for Unresectable Stage Ⅲ Non-Small-Cell Lung Cancer

Lung Cancer
West Japan Thoracic Oncology Group

Completed

A Randomized Phase III Trial of Chemotherapy Alone Versus Chemotherapy Followed by Gefitinib in Stage IIIB/IV Non-Small Cell Lung Cancer

Lung Cancer
Academic Thoracic Oncology Medical Investigators...
University of Colorado, Denver; Celgene Corporation; Criterium, Inc.

Active, not recruiting

Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates

Pancreatic Cancer | Pancreatic Adenocarcinoma | Pancreas Ductal Adenocarcinoma

United States
Thorsten Rudroff

Completed

Transcranial Direct Current Stimulation and Walking in Multiple Sclerosis

Transcranial Direct Current Stimulation

United States
Thorsten Gruenheid

Completed

Transfer Accuracy of 3D-printed Indirect Bonding Trays

Dental Bonding

United States
West Japan Thoracic Oncology Group

Unknown

Phase III Study of Gemcitabine Compared With UFT in Patients With Completely Resected Pathological Stage IB-IIIa Non Small Cell Lung Cancer

Lung Cancer

Japan
Thorsten Rudroff

Recruiting

tDCS for Post COVID-19 Fatigue

Post Covid-19 Patients

United States
Thorsten Rudroff

Completed

Cerebellar Transcranial Direct Current Stimulation in Parkinson's Disease

Parkinson Disease | Brain Stimulation | Cerebellum

United States
Thorsten Rudroff

Completed

Cannabis and Aging

Cannabis Use

United States
West Japan Thoracic Oncology Group

Completed

Phase III Study of Docetaxel Vs Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer

Lung Cancer
Thorasys Thoracic Medical Systems Inc.
MedTeq

Not yet recruiting

Proof-of-concept of the Measurement of Lung Function Using the Relaxed Expiratory Occlusion Monitor (REOM)

Asthma in Children

Canada
Stanford University
Society of Thoracic Radiology

Withdrawn

Clinical Validation of Machine Learning Triage of Chest Radiographs

Chest--Diseases

United States
Johns Hopkins University
American Thoracic Society

Completed

A Study of Novel Smoking Cessation Interventions in Current and Former Injection Drug Users

Tobacco Dependence

United States
University of Chicago
American Thoracic Society

Completed

Virtual Teach to Goal vs. Brief Intervention Inhaler Study-outpatient

Asthma in Children

United States
National Jewish Health
American Thoracic Society

Completed

The Effect of N-Acetyl-L-Cysteine, on Inflammatory and Oxidative Stress Markers in Pulmonary Sarcoidosis

Pulmonary Sarcoidosis

United States
Boston Scientific Corporation
Guidant Corporation

Completed

Septal - Success Rate and Clinical Outcome of Septal Implant of Ventricular Defibrillation Lead

Ventricular Fibrillation | Ventricular Tachycardia

France
Boston Scientific Corporation
Guidant Corporation

Completed

Shockless Implant Evaluation (SIMPLE)

Ventricular Fibrillation | Ventricular Tachycardia

Germany, Spain, Canada, Israel, Netherlands, France, Finland, United Kingdom, Austria, Malaysia, Thailand, Hong Kong, Sweden, Hungary, Australia, Czechia, Norway, Poland

Clinical Trials Sponsored by Thoratec Corporation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jordan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations